Jane Street Group, LLC Candel Therapeutics, Inc. Call Options Transaction History

Jane Street Group, LLC

  • $481 Billion
  • Q2 2025

Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2025

Aug 14, 2025
BUY
$4.39 - $6.04 $395,978 - $544,808
90,200 Added 160.78%
146,300 $740,000
Q1 2025

May 14, 2025
BUY
$5.65 - $12.21 $146,335 - $316,239
25,900 Added 85.76%
56,100 $316,000
Q4 2024

Feb 14, 2025
BUY
$3.96 - $9.96 $119,592 - $300,792
30,200 New
30,200 $262,000

Others Institutions Holding CADL

# of Institutions
84
Shares Held
15.3M
Call Options Held
570K
Put Options Held
203K
View Full List

About Candel Therapeutics, Inc.

CADL Quotes by TradingView
  • Ticker CADL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,891,900
  • Market Cap $183M
  • Description
  • Candel Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in the development immunotherapies for the cancer patients. The company develops CAN-2409, which is in Phase II clinical trails for the treatment of pancreatic cancer; Phase III clinical trials for the treatment of prostate cancer; and Phase II clinical trials for the...
More about CADL
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email